Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
Open accessThe DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Abstract
SUMMARY: Neisseria gonorrhoeae is evolving into a superbug with resistance to previously and currently recommended antimicrobials for treatment of gonorrhea, which is a major public health concern globally. Given the global nature of gonorrhea, the high rate of usage of antimicrobials, suboptimal control and monitoring of antimicrobial resistance (AMR) and treatment failures, slow update of treatment guidelines in most geographical settings, and the extraordinary capacity of the gonococci to develop and retain AMR, it is likely that the global problem of gonococcal AMR will worsen in the foreseeable future and that the severe complications of gonorrhea will emerge as a silent epidemic. By understanding the evolution, emergence, and spread of AMR in N. gonorrhoeae , including its molecular and phenotypic mechanisms, resistance to antimicrobials used clinically can be anticipated, future methods for genetic testing for AMR might permit region-specific and tailor-made antimicrobial therapy, and the design of novel antimicrobials to circumvent the resistance problems can be undertaken more rationally. This review focuses on the history and evolution of gonorrhea treatment regimens and emerging resistance to them, on genetic and phenotypic determinants of gonococcal resistance to previously and currently recommended antimicrobials, including biological costs or benefits; and on crucial actions and future advances necessary to detect and treat resistant gonococcal strains and, ultimately, retain gonorrhea as a treatable infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“Gonococci, like other bacteria (291), have the ability to form biofilms under laboratory conditions, and this community life-style also likely exists during infection (292, 293). growing in biofilms are often more resistant to antimicrobials than planktonic counterparts, and this property should be…”
BackgroundChopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · cited 1×
“…this by its resemblance to elongation factor G (EF-G), involved in protein synthesis, and TetM also has ribosome-dependent GTPase activity (205–207). initially established itself in gonococci by integrating into the 5-MDa conjugative plasmid to produce a 25.2-MDa (40.6 kb) plasmid(208,209).”
BackgroundInfluentialPrevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Cohen, M. S., Hoffman, I. F., Royce, R. A., Kazembe, P., Dyer, J. R., Daly, C. C., Zimba, D., Vernazza, P. L., Maida, M., Fiscus, S. A., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02190-9 · Cited by 872
Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-I., Kitawaki, J., & Unemo, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-11 · Cited by 686
Self-citationUnemo, M., Golparian, D., Nicholas, R., Ohnishi, M., Gallay, A., & Sednaoui, P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05760-11 · Cited by 653
Self-citationThe molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research
Gottesman, M. M., & Ling, V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.060 · Cited by 558
PENICILUNASE-PRODUCING NEISSERIA GONORRH$OElig;q
ASHFORD, W. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92467-3 · Cited by 557
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
Bignell, C., Unemo, M., The European STI Guidelines Editorial Board, Radcliffe, K., Jensen, J. S., Babayan, K., Barton, S., Cusini, M., Gomberg, M., Janier, M., et al. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462412472837 · Cited by 483
Self-citationThe Scars of Venus: A History of Venereology
Oriel, J. D. (1994) · Springer eBooks · doi:10.1007/978-1-4471-2068-1 · Cited by 438
Emergence of Multidrug-Resistant, Extensively Drug-Resistant and Untreatable Gonorrhea
Unemo, M., & Nicholas, R. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.117 · Cited by 421
Self-citationShafer, W. M., Qu, X.-D., Waring, A. J., & Lehrer, R. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1829 · Cited by 391
Self-citationHagman, K. E., Spratt, B. G., Balthazar, J. T., Pan, W., Judd, R. C., & Shafer, W. M. (1995) · Microbiology · doi:10.1099/13500872-141-3-611 · Cited by 368
Self-citationGoodman, S. D., & Scocca, J. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6982 · Cited by 349
Camara, J., Serra, J., Ayats, J., Bastida, T., Carnicer-Pont, D., Andreu, A., & Ardanuy, C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks162 · Cited by 339
Morse, S. A., Johnson, S. R., Biddle, J. W., & Roberts, M. C. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.5.664 · Cited by 313
Tapsall, J. W., Ndowa, F., Lewis, D. A., & Unemo, M. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.63 · Cited by 297
Self-citationThe Emerging Threat of Untreatable Gonococcal Infection
Bolan, G. A., Sparling, P. F., & Wasserheit, J. N. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1112456 · Cited by 279
Spratt, B., Bowler, L., Zhang, Q.-Y., Zhou, J., & Smith, J. (1992) · Journal of Molecular Evolution · doi:10.1007/bf00182388 · Cited by 270
UK national guideline for the management of gonorrhoea in adults, 2011
Bignell, C., FitzGerald, M., & (Guideline Development Group) (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.011267 · Cited by 270
(2013) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.10.014 · Cited by 259
Biological cost and compensatory evolution in fusidic acid‐resistant Staphylococcus aureus
Nagaev, I., Björkman, J., Andersson, D. I., & Hughes, D. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02389.x · Cited by 257
Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae
Spratt, B. G. (1988) · Nature · doi:10.1038/332173a0 · Cited by 253
(2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.06.012 · Cited by 253
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli
Sigmund, C. D., Ettayebi, M., & Morgan, E. A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.11.4653 · Cited by 243
Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus
Unemo, M. (2013) · Cited by 236
Self-citationCathelicidin LL-37: A Multitask Antimicrobial Peptide
Bucki, R., Leszczyńska, K., Namiot, A., & Sokołowski, W. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0057-2 · Cited by 235
Unemo, M., & Shafer, W. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06215.x · Cited by 230
Self-citationNatural transformation of Neisseria gonorrhoeae: from DNA donation to homologous recombination
Hamilton, H. L., & Dillard, J. P. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04964.x · Cited by 229
Unemo, M., Fasth, O., Fredlund, H., Limnios, A., & Tapsall, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp098 · Cited by 226
Self-citationAmeyama, S., Onodera, S., Takahata, M., Minami, S., Maki, N., Endo, K., Goto, H., Suzuki, H., & Oishi, Y. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3744-3749.2002 · Cited by 222
Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada
Allen, V. G., Mitterni, L., Seah, C., Rebbapragada, A., Martin, I. E., Lee, C., Siebert, H., Towns, L., Melano, R. G., & Low, D. E. (2013) · JAMA · doi:10.1001/jama.2012.176575 · Cited by 212
Jerse, A. E., Sharma, N. D., Simms, A. N., Crow, E. T., Snyder, L. A., & Shafer, W. M. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5576-5582.2003 · Cited by 209
Self-citationBowler, L. D., Zhang, Q. Y., Riou, J. Y., & Spratt, B. G. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.2.333-337.1994 · Cited by 208
Ito, M., Deguchi, T., Mizutani, K.-S., Yasuda, M., Yokoi, S., Ito, S.-I., Takahashi, Y., Ishihara, S., Kawamura, Y., & Ezaki, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.137-143.2005 · Cited by 205
Drugs of Choice for the Treatment of Uncomplicated Gonococcal Infections
Moran, J. S., & Levine, W. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_1.s47 · Cited by 202
Grad, Y. H., Kirkcaldy, R. D., Trees, D., Dordel, J., Harris, S. R., Goldstein, E., Weinstock, H., Parkhill, J., Hanage, W. P., Bentley, S., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70693-5 · Cited by 201
Cáceres, A., Menéndez, H., Méndez, E., Cohobón, E., Samayoa, B. E., Jauregui, E., Peralta, E., & Carrillo, G. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)01288-o · Cited by 200
Penicillinase-producing Neisseria gonorrhoeae.
(1982) · Europe PMC (PubMed Central) · Cited by 198
Update on the Management of Gonorrhea in Adults in the United States
Newman, L. M., Moran, J. S., & Workowski, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/511422 · Cited by 197
Warner, D. M., Shafer, W. M., & Jerse, A. E. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06424.x · Cited by 192
Self-citationChisholm, S. A., Dave, J., & Ison, C. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00309-10 · Cited by 192
Nucleic Acid Amplification Testing for Neisseria gonorrhoeae
Whiley, D. M., Tapsall, J. W., & Sloots, T. P. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050045 · Cited by 192
Unemo, M., Golparian, D., Syversen, G., Vestrheim, D. F., & Moi, H. (2010) · Eurosurveillance · doi:10.2807/ese.15.47.19721-en · Cited by 185
Self-citationVeal, W. L., Nicholas, R. A., & Shafer, W. M. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.20.5619-5624.2002 · Cited by 176
Self-citationTranscriptional control of the mtr efflux system of Neisseria gonorrhoeae
Hagman, K. E., & Shafer, W. M. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4162-4165.1995 · Cited by 174
Self-citationCephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?
Chisholm, S. A., Mouton, J. W., Lewis, D. A., Nichols, T., Ison, C. A., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq289 · Cited by 174
Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010
Ison, C. A., Hussey, J., Sankar, K. N., Evans, J., & Alexander, S. (2011) · Eurosurveillance · doi:10.2807/ese.16.14.19833-en · Cited by 172
The structure of ribosomal protein S5 reveals sites of interaction with 16S rRNA
Ramakrishnan, V., & White, S. W. (1992) · Nature · doi:10.1038/358768a0 · Cited by 168
National Surveillance of Antimicrobial Resistance in Neisseria gonorrhoeae
Schwarcz, S. K. (1990) · JAMA · doi:10.1001/jama.264.11.1413 · Cited by 168
Drake, S. L., & Koomey, M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.18050975.x · Cited by 168
The Gonococcus fights back: is this time a knock out?
Lewis, D. A. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2010.042648 · Cited by 168
A variety of Gram-positive bacteria carry mobile mef genes
Luna, V. A., Coates, P., Eady, E. A., Cove, J. H., Nguyen, T. T. H., & Roberts, M. C. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.1.19 · Cited by 168
Sparling, P. F., Sarubbi, F. A., & Blackman, E. (1975) · Journal of Bacteriology · doi:10.1128/jb.124.2.740-749.1975 · Cited by 167
Mutation in 23S rRNA Associated with Macrolide Resistance in Neisseria gonorrhoeae
Ng, L.-K., Martin, I., Liu, G., & Bryden, L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3020-3025.2002 · Cited by 167
Threat to Cefixime Treatment for Gonorrhea
Yokoi, S., Deguchi, T., Ozawa, T., Yasuda, M., Ito, S.-I., Kubota, Y., Tamaki, M., & Maeda, S.-I. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1308.060948 · Cited by 162
Jaffe, H. W., Biddle, J. W., Thornsberry, C., Johnson, R. E., Kaufman, R. E., Reynolds, G. H., Wiesner, P. J., & The Cooperative Study Group (1976) · New England Journal of Medicine · doi:10.1056/nejm197601012940102 · Cited by 162
Zhao, S., Duncan, M., Tomberg, J., Davies, C., Unemo, M., & Nicholas, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00304-09 · Cited by 161
Self-citationInhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.
Lomovskaya, O., & Watkins, W. (2001) · PubMed · Cited by 161
The use of cephalosporins for gonorrhea: the impending problem of resistance
Barry, P. M., & Klausner, J. D. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902731993 · Cited by 161
Are pleuromutilin antibiotics finally fit for human use?
Novak, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06219.x · Cited by 160
Antibiotic Resistance inNeisseria gonorrhoeae
TAPSALL, J. W. (2005) · Clinical Infectious Diseases · doi:10.1086/430787 · Cited by 160
Lee, E. H., & Shafer, W. M. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01530.x · Cited by 159
Self-citationGill, M. J., Simjee, S., Al-Hattawi, K., Robertson, B. D., EASMON, C. S. F., & ISON, C. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2799 · Cited by 158
Unemo, M., Golparian, D., & Hestner, A. (2011) · Eurosurveillance · doi:10.2807/ese.16.06.19792-en · Cited by 155
Self-citationBiochemical and genetic characterization of the action of triclosan on Staphylococcus aureus
Slater-Radosti, C., Aller, G. V., Greenwood, R., Nicholas, R., Keller, P. M., DeWolf, W. E., Fan, F., Payne, D. J., & Jaworski, D. D. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.1 · Cited by 154
Olesky, M., Zhao, S., Rosenberg, R. L., & Nicholas, R. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2300-2308.2006 · Cited by 153
Unemo, M., & Dillon, J. R. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-10 · Cited by 151
Self-citationFitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniae
Rozen, D. E., McGee, L., Levin, B. R., & Klugman, K. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01161-06 · Cited by 151
Palmer, H. M., Mallinson, H., Wood, R. L., & Herring, A. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.835-837.2003 · Cited by 149
Tabrizi, S. N., Unemo, M., Limnios, A. E., Hogan, T. R., Hjelmevoll, S. O., Sm, G., & TAPSALL, J. W. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01217-11 · Cited by 149
Self-citationBoslego, J. W., Tramont, E. C., Takafuji, E. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707303170504 · Cited by 149
Olesky, M., Hobbs, M. M., & Nicholas, R. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2811-2820.2002 · Cited by 148
Drake, S. L., Sandstedt, S. A., & Koomey, M. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2511618.x · Cited by 148
HANDSFIELD, H. H., DALU, Z. A., MARTIN, D. H., DOUGLAS, J. M., MCCARTY, J. M., SCHLOSSBERG, D., & STUDY GROUP, A. G. (1994) · Sexually Transmitted Diseases · doi:10.1097/00007435-199403000-00010 · Cited by 146
Dillon, J. R., Yei, K.-H., Pauzé, M., & Yeung, K.-H. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91846-9 · Cited by 146
Hu, M. Y., Nandi, S., Davies, C., & Nicholas, R. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4327-4334.2005 · Cited by 146
Decreased Azithromycin Susceptibility of Neisseria gonorrhoeae Due to mtrR Mutations
Zarantonelli, L., Borthagaray, G., Lee, E.-H., & Shafer, W. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2468 · Cited by 144
Self-citationTomberg, J., Unemo, M., Davies, C., & Nicholas, R. A. (2010) · Biochemistry · doi:10.1021/bi101167x · Cited by 142
Self-citationBurdett, V (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49928-0 · Cited by 141
Chisholm, S., Unemo, M., Quaye, N., Johansson, E. K., Cole, M. J., ISON, C. A., & van de Laar, M. J. W. (2013) · Eurosurveillance · doi:10.2807/ese.18.03.20358-en · Cited by 140
Self-citationUnemo, M., Golparian, D., Stary, A., & Eigentler, A. (2011) · Eurosurveillance · doi:10.2807/ese.16.43.19998-en · Cited by 139
Self-citationISON, C. A., Town, K., Obi, C., Chisholm, S., Hughes, G., Livermore, D. M., & Lowndes, C. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70143-9 · Cited by 137
Douthwaite, S. R., & Champney, W. S. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_2.1 · Cited by 136
Rouquette-Loughlin, C., Dunham, S. A., Kuhn, M., Balthazar, J. T., & Shafer, W. M. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.3.1101-1106.2003 · Cited by 129
Self-citationWarner, D. M., Folster, J. P., Shafer, W. M., & Jerse, A. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/522964 · Cited by 128
Self-citationShafer, W. M., Balthazar, J. T., Hagman, K. E., & Morse, S. A. (1995) · Microbiology · doi:10.1099/13500872-141-4-907 · Cited by 128
Self-citationMartin, I. M. C., Hoffmann, S., & Ison, C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl265 · Cited by 127
Streptococcal tetracycline resistance mediated at the level of protein synthesis
Burdett, V (1986) · Journal of Bacteriology · doi:10.1128/jb.165.2.564-569.1986 · Cited by 126
Comparative Study of Gonococcal Susceptibility to Penicillin in the United States, 1955-1969
Martin, J. E., Lester, A. M., Price, E. V., & Schmale, J. D. (1970) · The Journal of Infectious Diseases · doi:10.1093/infdis/122.5.459 · Cited by 125
Whiley, D. M., Limnios, E. A., Ray, S., Sloots, T. P., & TAPSALL, J. W. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00306-07 · Cited by 125
Hagman, K. E., Lucas, C. E., Balthazar, J. T., Snyder, L. A. S., Nilles, M. L., Judd, R. C., & Shafer, W. M. (1997) · Microbiology · doi:10.1099/00221287-143-7-2117 · Cited by 120
Self-citationThe MtrR repressor binds the DNA sequence between the mtrR and mtrC genes of Neisseria gonorrhoeae
Lucas, C. E., Balthazar, J. T., Hagman, K. E., & Shafer, W. M. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.13.4123-4128.1997 · Cited by 120
Self-citationCharacterization of the MacA–MacB efflux system in Neisseria gonorrhoeae
Rouquette-Loughlin, C. E., Balthazar, J. T., & Shafer, W. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki333 · Cited by 119
Self-citationEmergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland
Palmer, H. M., Young, H.-K., Winter, A., & Dave, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn235 · Cited by 117
Lewis, D. A., Sriruttan, C., Muller, E. E., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt034 · Cited by 117
Morse, S. A., Lysko, P. G., McFarland, L. L., Knapp, J. S., Sandström, E., Critchlow, C. W., & Holmes, K. K. (1982) · Infection and Immunity · doi:10.1128/iai.37.2.432-438.1982 · Cited by 114
Katz, A. R., Komeya, A. Y., Soge, O. O., Kiaha, M., Lee, M. V. C., Wasserman, G. M., Maningas, E. V., Whelen, A. C., Kirkcaldy, R. D., Shapiro, S. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir929 · Cited by 114
Correia, F. F., Inouye, S., & Inouye, M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37738-x · Cited by 113
Tanaka, M., Nakayama, H., Huruya, K., Konomi, I., Irie, S., Kanayama, A. K., Saika, T., & Kobayashi, I. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.08.021 · Cited by 109
Biofilm Formation by Neisseria gonorrhoeae
Greiner, L. L., Edwards, J. L., Shao, J., Rabinak, C., Entz, D., & Apicella, M. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.1964-1970.2005 · Cited by 108
Unemo, M., Golparian, D., Potočnik, M., & Jeverica, S. (2012) · Eurosurveillance · doi:10.2807/ese.17.25.20200-en · Cited by 106
Self-citationMoran, J. S. (1995) · Sexually Transmitted Diseases · doi:10.1097/00007435-199501000-00007 · Cited by 106
Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism
Mayer, C., & Janin, Y. L. (2013) · Chemical Reviews · doi:10.1021/cr4003984 · Cited by 106
Powell, A. J., Tomberg, J., Deacon, A. M., Nicholas, R. A., & Davies, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805761200 · Cited by 105
Roberts, M. C., Chung, W. O., Roe, D. E., Xia, M., Márquez, C., Borthagaray, G., Whittington, W. L. H., & Holmes, K. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1367 · Cited by 105
Deguchi, T., Yasuda, M., Yokoi, S., et al. (2003) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-002-0204-8 · Cited by 104
Kuete, V., Ngameni, B., Mbaveng, A. T., Ngadjui, B., Meyer, J. J. M., & Lall, N. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2010.06.005 · Cited by 101
Brannigan, J. A., Tirodimos, I., Zhang, Q. ‐., Dowson, C. G., & Spratt, B. G. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00664.x · Cited by 100
Zhao, S., Tobiason, D. M., Hu, M. Y., Seifert, H. S., & Nicholas, R. A. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04752.x · Cited by 99
Alm, R. A., Lahiri, S. D., Kutschke, A., Otterson, L. G., McLaughlin, R. E., Whiteaker, J. D., Lewis, L. A., Su, X., Huband, M. D., Gardner, H., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04456-14 · Cited by 99
The effect of Epidermal Growth Factor on Membrane Potential
Pandiella, A., Magni, M., Lovisolo, D., & Meldolesi, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51575-1 · Cited by 98
Luna, V. A., Cousin, S., Whittington, W. L. H., & Roberts, M. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2503-2506.2000 · Cited by 96
Unemo, M., Golparian, D., Skogen, V., Olsen, A. O., Moi, H., Syversen, G., & Hjelmevoll, S. O. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01775-12 · Cited by 95
Self-citationFermer, C., Kristiansen, B. E., Sköld, O., & Swedberg, G. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.16.4669-4675.1995 · Cited by 94
Kunz, A. N., Begum, A. A., Wu, H., D'Ambrozio, J. A., Robinson, J. M., Shafer, W. M., Bash, M. C., & Jerse, A. E. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis277 · Cited by 94
Self-citationShimuta, K., Unemo, M., Nakayama, S., Morita‐Ishihara, T., Dorin, M., Kawahata, T., & Ohnishi, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01295-13 · Cited by 93
Self-citationOhneck, E. A., Zalucki, Y. M., Johnson, P. J., Dhulipala, V., Golparian, D., Unemo, M., Jerse, A. E., & Shafer, W. M. (2011) · mBio · doi:10.1128/mbio.00187-11 · Cited by 92
Self-citationRouquette, C., Harmon, J. B., & Shafer, W. M. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01517.x · Cited by 91
Self-citationOsaka, K., Takahata, M., Takakura, T., Narukawa, K., Endo, K., Kiyota, H., & Onodera, S. (2008) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-008-0610-7 · Cited by 90
The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound
Escaich, S., Prouvensier, L., Saccomani, M., Durant, L., Oxoby, M., Gerusz, V. J., Moreau, F., Vongsouthi, V., Maher, K., Morrissey, I., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01248-10 · Cited by 90
Tomberg, J., Unemo, M., Ohnishi, M., Davies, C., & Nicholas, R. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-13 · Cited by 88
Self-citationFailure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia
Y. Chen, M., Stevens, K., Tideman, R., Zaia, A., Tomita, T., Fairley, C. K., Lahra, M., Whiley, D., & Hogg, G. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt017 · Cited by 87
Pandori, M., Barry, P. M., Wu, A., Ren, A., Whittington, W. L. H., Liska, S., & Klausner, J. D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00406-09 · Cited by 87
SPECTINOMYCIN-RESISTANT PENICILLINASE-PRODUCING NEISSERIA GONORRHOEAE
Ashford, W. A., Adams, H. U., Johnson, S. R., et al. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91227-7 · Cited by 86
Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy
Starnino, S., Stefanelli, P., & on behalf of the Neisseria gonorrhoeae Italian Study Group (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp118 · Cited by 86
Akasaka, S., Muratani, T., Yamada, Y., Inatomi, H., Takahashi, K., & Matsumoto, T. (2001) · Journal of Infection and Chemotherapy · doi:10.1007/s101560170034 · Cited by 85
Knapp, J. S., Johnson, S. R., Zenilman, J. M., Roberts, M. C., & Morse, S. A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.765 · Cited by 83
Cousin, S., Whittington, W. L. H., & Roberts, M. C. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg040 · Cited by 81
Kirkcaldy, R. D., Kidd, S. E., Weinstock, H., Papp, J. R., & BOLAN, G. A. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051162 · Cited by 80
Dillon, J.-A. R., & Yeung, K. H. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.suppl.s125 · Cited by 77
Ceftibuten Resistance and Treatment Failure ofNeisseria gonorrhoeaeInfection
Lo, J. Y. C., Ho, K., Leung, A. O. C., Tiu, F. S. T., Tsang, G. K. L., Lo, A. C. T., & TAPSALL, J. W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00198-08 · Cited by 77
Mutations in gyrA, gyrB, parC, and parE in quinolone‐resistant strains of Neisseria gonorrhoeae
Lindbäck, E., Rahman, M., Jalal, S., et al. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.1100909.x · Cited by 75
Rouquette‐Loughlin, C. E., Balthazar, J. T., Hill, S. A., & Shafer, W. M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04299.x · Cited by 74
Self-citationAzithromycin and erythromycin resistant Neisseria gonorrhoea e following treatment with azithromycin
Young, H.-K., Moyes, A., & McMillan, A. (1997) · International Journal of STD & AIDS · doi:10.1258/0956462971920127 · Cited by 73
The Composition and Metabolic Phenotype of Neisseria gonorrhoeae Biofilms
Falsetta, M. L., Steichen, C. T., McEwan, A. G., Cho, C., Ketterer, M. R., Shao, J., Hunt, J. R., Jennings, M. P., & Apicella, M. A. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00075 · Cited by 73
Shokeen, P., Ray, K., Bala, M., & Tandon, V. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000152821.23777.90 · Cited by 71
Olsen, B., Làn, P. T., Golparian, D., Johansson, E. K., Khang, T. H., & Unemo, M. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-40 · Cited by 70
Self-citationIntroduction of Sulfonamide Therapy for Gonorrhea
KAMPMEIER, R. H. (1983) · Sexually Transmitted Diseases · doi:10.1097/00007435-198304000-00007 · Cited by 69
Ndowa, F. J., Narasimhan, M., & Unemo, M. (2012) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050674 · Cited by 67
Self-citationZarantonelli, L., Borthagaray, G., Lee, E. H., Veal, W., & Shafer, W. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.651 · Cited by 67
Self-citationDavies, C., Bussiere, D. E., Golden, B. L., Porter, S. J., Ramakrishnan, V., & White, S. W. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1780 · Cited by 66
Bala, M., Kakran, M., Singh, V., Sood, S., Ramesh, V., & Members of the WHO GASP SEAR Network (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050904 · Cited by 66
Trzciński, K., Thompson, C. M., Gilbey, A. M., Dowson, C. G., & Lipsitch, M. (2006) · The Journal of Infectious Diseases · doi:10.1086/501367 · Cited by 64
Hobbs, M. M., Anderson, J. E., Balthazar, J. T., Kandler, J. L., Carlson, R. W., Ganguly, J., Begum, A. A., Duncan, J. A., Lin, J. T., Sparling, P. F., et al. (2013) · mBio · doi:10.1128/mbio.00892-13 · Cited by 63
Self-citationMartín, I., Sawatzky, P., Allen, V. G., Hoang, L., Lefebvre, B., Mina, N. V., Wong, T., & Gilmour, M. W. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182401b69 · Cited by 63
Transformation-derived Neisseria gonorrhoeae plasmids with altered structure and function
Sox, T. E., Mohammed, W., & Sparling, P. F. (1979) · Journal of Bacteriology · doi:10.1128/jb.138.2.510-518.1979 · Cited by 62
Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
Falagas, M. E., Karageorgopoulos, D. E., & Dimοpoulos, G. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048356 · Cited by 62
Alexander, B. T., Marschall, J., Tibbetts, R. J., Neuner, E. A., Dunne, W. M., & Ritchie, D. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.05.002 · Cited by 60
Neisseria gonorrhoeae modulates iron-limiting innate immune defenses in macrophages
Zughaier, S. M., Kandler, J. L., & Shafer, W. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087688 · Cited by 59
MtrR Modulates rpoH Expression and Levels of Antimicrobial Resistance in Neisseria gonorrhoeae
Folster, J. P., Johnson, P. J., Jackson, L. A., Dhulipali, V., Dyer, D. W., & Shafer, W. M. (2008) · Journal of Bacteriology · doi:10.1128/jb.01165-08 · Cited by 59
Self-citationRead, P. J., Limnios, E. A., McNulty, A. M., Whiley, D. M., & Lahra, M. M. (2013) · Sexual Health · doi:10.1071/sh13077 · Cited by 57
Veal, W. L., & Shafer, W. M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg031 · Cited by 57
Self-citationC.G. Paine and the earliest surviving clinical records of penicillin therapy
Wainwright, M., & Swan, H. (1986) · Medical History · doi:10.1017/s0025727300045026 · Cited by 55
Mutation in ribosomal protein S5 leads to spectinomycin resistance in Neisseria gonorrhoeae
Ilina, E. N., Malakhova, M. V., Bodoev, I. N., Oparina, N. Y., Filimonova, A. V., & Govorun, V. M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00186 · Cited by 55
Roberts, M. C., & Knapp, J. S. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.4.488 · Cited by 53
Starnino, S., Galarza, P. G., Carvallo, M. E. T., Benzaken, A. S., Ballesteros, A. M., Cruz, O. M. S., Hernández, A. L., Carbajal, J. L. P., Borthagaray, G., Payares, D., et al. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182631c9f · Cited by 50
Paulsen, I. T., & Lewis, K. (2002) · Cited by 49
Spiteri, G., Cole, M. J., Unemo, M., Hoffmann, S., ISON, C. A., & van de Laar, M. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051117 · Cited by 49
Self-citationShokeen, P., Bala, M., Singh, V., & Tandon, V. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.03.018 · Cited by 48
Chen, C.-J., Tobiason, D. M., Thomas, C. E., Shafer, W. M., Seifert, H. S., & Sparling, P. F. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.3.730-739.2004 · Cited by 48
Self-citationGoytia, M., & Shafer, W. M. (2010) · Infection and Immunity · doi:10.1128/iai.01301-09 · Cited by 48
Self-citationOchiai, S., Ishiko, H., Yasuda, M., & Deguchi, T. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01800-07 · Cited by 48
Point Mutations in the Dihydropteroate Synthase Gene Causing Sulfonamide Resistance
Swedberg, G., Fermér, C., & Sköld, O. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2960-6_113 · Cited by 47
Xia, M., Whittington, W. L. H., Shafer, W. M., & Holmes, K. K. (2000) · The Journal of Infectious Diseases · doi:10.1086/315510 · Cited by 43
Self-citationDillon, J. R., Trecker, M. A., Thakur, S. D., & on behalf of the Gonococcal Antimicrobial Surveillance Program Network in Latin America and the Caribbean 1990–2011 (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050905 · Cited by 41
Current and future treatment options for gonorrhoea
ISON, C. A., Deal, C. D., & Unemo, M. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050913 · Cited by 41
Self-citationFolster, J. P., Dhulipala, V., Nicholas, R. A., & Shafer, W. M. (2007) · Journal of Bacteriology · doi:10.1128/jb.00286-07 · Cited by 40
Self-citationDeshpande, L. M., Gales, A. C., & Jones, R. N. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00355-7 · Cited by 39
Fluoroquinolone Resistance Among Neisseria gonorrhoeae Isolates in Hawaii, 1990–2000
Iverson, C. J., Wang, S. A., Lee, M. V., Ohye, R. G., Trees, D. L., Knapp, J. S., Effler, P. V., O’Connor, N. P., & Levine, W. C. (2004) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000145846.45781.a4 · Cited by 38
Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae
Johnson, S. R., Sandul, A. L., Parekh, M., Wang, S. A., Knapp, J. S., & Trees, D. L. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00039-6 · Cited by 38
The Iron-Repressed, AraC-Like Regulator MpeR Activates Expression of fetA in Neisseria gonorrhoeae
Hollander, A., Mercante, A. D., Shafer, W. M., & Cornelissen, C. N. (2011) · Infection and Immunity · doi:10.1128/iai.05806-11 · Cited by 38
Self-citationMercante, A. D., Jackson, L. A., Johnson, P. J., Stringer, V. A., Dyer, D. W., & Shafer, W. M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06112-11 · Cited by 37
Self-citationUnemo, M., ISON, C. A., Cole, M. J., Spiteri, G., van de Laar, M., & Khotenashvili, L. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050909 · Cited by 37
Self-citationIn vitro antigonococcal activity of Coscinium fenestratum stem extract
Chomnawang, M. T., Trinapakul, C., & Gritsanapan, W. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.01.036 · Cited by 36
ISON, C. A. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834e9a6a · Cited by 35
Ilina, E. N., Vereshchagin, V. A., Borovskaya, A. D., Malakhova, M. V., Sv, S., Al-Khafaji, N. C., Kubanova, A. A., & Govorun, V. M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01420-07 · Cited by 35
Goire, N., Ohnishi, M., Limnios, A. E., Lahra, M. M., Lambert, S. B., Nimmo, G. R., Nissen, M. D., Sloots, T. P., & Whiley, D. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr549 · Cited by 32
Zalucki, Y. M., Dhulipala, V., & Shafer, W. M. (2012) · mBio · doi:10.1128/mbio.00446-12 · Cited by 31
Self-citationGonococcal antimicrobial resistance in the Western Pacific Region
Lahra, M. M., Lo, Y.-R. J., & Whiley, D. M. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050906 · Cited by 31
Ikeda, F., Tsuji, A., Kaneko, Y., et al. (1986) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1986.tb03000.x · Cited by 30
Gonococcal antimicrobial resistance: perspectives from the African region
Ndowa, F. J., Francis, J. M., Machiha, A., Faye-Ketté, H., & Fonkoua, M. C. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050907 · Cited by 30
Shafer, W. M., & Folster, J. P. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2297-2299.2006 · Cited by 30
Self-citationGoire, N., Lahra, M. M., Ohnishi, M., Hogan, T. A., Liminios, A. E., Nissen, M. D., Sloots, T. P., & Whiley, D. M. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.14.20444 · Cited by 20
Fujimoto, K., Takemoto, K., Hatano, K., Nakai, T., Terashita, S., Matsumoto, M., Eriguchi, Y., Eguchi, K., Shimizudani, T., Sato, K., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01051-12 · Cited by 20
Johnson, P. J., Stringer, V. A., & Shafer, W. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00010-11 · Cited by 20
Self-citationTomberg, J., Temple, B. R. S., Fedarovich, A., Davies, C., & Nicholas, R. A. (2012) · Biochemistry · doi:10.1021/bi2017987 · Cited by 19
Takahashi, S., Kurimura, Y., Hashimoto, J., Uehara, T., Hiyama, Y., Tsukamoto, T., Iwasawa, A., Nishimura, M., Sunaoshi, K., Takeda, K., et al. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0450-3 · Cited by 18
Vernel-Pauillac, F., Falcot, V., Whiley, D. M., & Mérien, F. (2005) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2005.00053.x · Cited by 15
Saika, T., Nishiyama, T., Kanayama, A. K., Kobayashi, I., Nakayama, H., Tanaka, M., & Naito, S. (2001) · Journal of Infection and Chemotherapy · doi:10.1007/s101560100031 · Cited by 15
Márquez, C., Dillon, J. R., Rodriguez, V. I., & Borthagaray, G. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200212000-00010 · Cited by 12
And The Nimh Collaborative Hiv/Std Prevention Trial Group, Siedner, M. J., Pandori, M., León, S. R., Barry, P. M., Espinosa, B. J., Hall, E. R., Coates, T. J., & Klausner, J. D. (2008) · International Journal of STD & AIDS · doi:10.1258/ijsa.2007.007206 · Cited by 10
Cited by
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
The negative impact of antibiotic resistance
Friedman, N. D., Temkin, E., & Carmeli, Y. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.002 · Cited by 870
Sexually transmitted infections: challenges ahead
Unemo, M., Bradshaw, C. S., Hocking, J. S., de Vries, H. J. C., Francis, S. C., Mabey, D., Marrazzo, J. M., Sonder, G. J. B., Schwebke, J. R., Hoornenborg, E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30310-9 · Cited by 751
Self-citationEllington, M. J., Ekelund, O., Aarestrup, F. M., Canton, R., Doumith, M., Giske, C., Grundman, H., Hasman, H., Holden, M. T. G., Hopkins, K. L., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.11.012 · Cited by 603
Wi, T., Lahra, M. M., Ndowa, F., Bala, M., Dillon, J.-A. R., Ramon-Pardo, P., Eremin, S. R., Bolan, G., & Unemo, M. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002344 · Cited by 600
Self-citation
Metadata
- Authors
- Unemo, M., & Shafer, W. M.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2014-07
- Volume
- 27
- Issue
- 3
- Pages
- 587-613
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W1967593111
- Cited by
- 1,151
- References
- 194
- FWCI
- 49.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.